Category:
Prophylactic Biological Products
CAS NO:
NA
Standard:
In-house Standards,
Empagliflozin/Linagliptin is a fixed-dose combination API for type 2 diabetes, integrating SGLT2 inhibition and DPP-4 blockade. Molecular formula: C30H39N5O6; CAS: 1380735-66-3.
Contraindicated in severe renal impairment or hypersensitivity. Store below 25°C in dry conditions. Handle with PPE to avoid inhalation exposure during powder processing.